Most companies don't survive for decades, much less pay regular dividends for that long. Healthcare leaders Merck (NYSE: MRK) ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Sam King's 9-year-old son was diagnosed with Type 1 diabetes.King, who is now an associate professor of computer science at ...

Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

ABU DHABI: AD Ports Group today signed a shareholders’ agreement with the CMA CGM Group, a global player in sea, land, air, and logistics solutions, through its subsidiary CMA Terminals, to jointly ...

Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...

Bristol Myers Squibb's Opdivo has been approved in a subcutaneous injection formulation by the FDA, making treatment easier for patients and potentially adding years to the product's patent life.

A subcutaneous formulation of MSD's top-selling cancer immunotherapy, Keytruda, was non-inferior to the current intravenous version in a head-to-head trial, setting up regulatory filings.

How CGM sensors work and how to look after them Use of Continuous Glucose Monitors by People With and Without Diabetes New continuous glucose monitoring system to transform diabetes care First author ...

Senseonics announced today that it filed for CE mark for its Eversense 365 continuous glucose monitor (CGM) system.

The technology enables simultaneous detection of subcutaneous tissues at different depths while effectively reducing background signal interference from the epidermis, or outermost layer of skin ...